The immune environment of ccRCC is distinct, marked by a high presence of immune cells like CD8+ T cells, regulatory T cells (Tregs), and tumor-associated macrophages (TAMs), alongside increased expression of immune checkpoint molecules such as CTLA4, PD-1, and LAG3 [14,15]. The gene discussed is CTLA4; the disease is neoplasm.